Gilead Sciences Inc’s antiviral drug, remdesivir, prevented lung disease in macaques infected with the new coronavirus, a study published in medical journal Nature said on Tuesday.

In the study, macaques that received remdesivir did not show signs of respiratory disease and had reduced damage to the lungs, according to the study authors.

Source : News 18

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.